feed,title,long_url,short_url
InvestorPlace,3 Highly Underrated Renewable Energy Stocks to Buy for 2024,https://investorplace.com/2023/12/3-highly-underrated-renewable-energy-stocks-to-buy-for-2024/,https://da.gd/K2lgT0
InvestorPlace,Shopping for Success: 3 Top Stocks in Consumer Discretionary Sector,https://investorplace.com/2023/12/shopping-for-success-3-top-stocks-in-consumer-discretionary-sector/,https://da.gd/2SpIEV
InvestorPlace,BBLG Stock Earnings: Bone Biologics Misses EPS for Q1 2023,https://investorplace.com/earning-results/2023/12/bblg-stock-earnings-bone-biologics-for-q1-of-2023/,https://da.gd/vVQ0Z
InvestorPlace,BBLG Stock Earnings: Bone Biologics Misses EPS for Q2 2023,https://investorplace.com/earning-results/2023/12/bblg-stock-earnings-bone-biologics-for-q2-of-2023/,https://da.gd/le9W
InvestorPlace,BBLG Stock Earnings: Bone Biologics Misses EPS for Q3 2023,https://investorplace.com/earning-results/2023/12/bblg-stock-earnings-bone-biologics-for-q3-of-2023/,https://da.gd/bV1AE
InvestorPlace,China Is Critical to the Stock Market in 2024: What to Watch,https://investorplace.com/2023/12/china-is-critical-to-the-stock-market-in-2024-what-to-watch/,https://da.gd/0TB3Y2
InvestorPlace,Can Walmart Save Affirm (AFRM) Stock?,https://investorplace.com/2023/12/can-walmart-save-affirm-afrm-stock/,https://da.gd/2y84VG
InvestorPlace,"TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Misses Revenue for Q1 2023",https://investorplace.com/earning-results/2023/12/tffp-stock-earnings-tff-pharmaceuticals-for-q1-of-2023/,https://da.gd/JR9X6
InvestorPlace,CYCC Stock Earnings: Cyclacel Pharmaceuticals Beats EPS for Q1 2023,https://investorplace.com/earning-results/2023/12/cycc-stock-earnings-cyclacel-pharmaceuticals-for-q1-of-2023/,https://da.gd/g9cvU2
InvestorPlace,YQ Stock Earnings: 17 Education & Technology Reported Results for Q1 2023,https://investorplace.com/earning-results/2023/12/yq-stock-earnings-17-education-technology-for-q1-of-2023/,https://da.gd/iod4EF
InvestorPlace,CYCC Stock Earnings: Cyclacel Pharmaceuticals Beats EPS for Q2 2023,https://investorplace.com/earning-results/2023/12/cycc-stock-earnings-cyclacel-pharmaceuticals-for-q2-of-2023/,https://da.gd/e4Mp2
InvestorPlace,"TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q2 2023",https://investorplace.com/earning-results/2023/12/tffp-stock-earnings-tff-pharmaceuticals-for-q2-of-2023/,https://da.gd/azbC
InvestorPlace,YQ Stock Earnings: 17 Education & Technology Reported Results for Q2 2023,https://investorplace.com/earning-results/2023/12/yq-stock-earnings-17-education-technology-for-q2-of-2023/,https://da.gd/qxj8
InvestorPlace,CYCC Stock Earnings: Cyclacel Pharmaceuticals Misses EPS for Q3 2023,https://investorplace.com/earning-results/2023/12/cycc-stock-earnings-cyclacel-pharmaceuticals-for-q3-of-2023/,https://da.gd/ooed0j
InvestorPlace,"TFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q3 2023",https://investorplace.com/earning-results/2023/12/tffp-stock-earnings-tff-pharmaceuticals-for-q3-of-2023/,https://da.gd/swGz
InvestorPlace,YQ Stock Earnings: 17 Education & Technology Reported Results for Q3 2023,https://investorplace.com/earning-results/2023/12/yq-stock-earnings-17-education-technology-for-q3-of-2023/,https://da.gd/XTdL2
InvestorPlace,"Hold Your Nose, and Hold C3.ai Stock â€˜Til 2030",https://investorplace.com/2023/12/hold-your-nose-and-hold-c3-ai-stock-til-2030/,https://da.gd/socz
InvestorPlace,Canopy Growth Just Enacted a 1-for-10 Reverse Split of CGC Stock,https://investorplace.com/2023/12/canopy-growth-just-enacted-a-1-for-10-reverse-split-of-cgc-stock/,https://da.gd/kxKM
